PPARG and systemic sclerosis: Although the cause underlying the PPARγ deficit in SSc and other fibrosing conditions is not yet known, multiple factors implicated in the pathogenesis of fibrosis, such as TGF-β, CTGF, and IL-13, potently inhibit PPARγ expression and function [3].